Advanced search
Publication Cover
Leukemia & Lymphoma Volume 62, 2021 - Issue 10
Submit an article Journal homepage
5,409
Views
6
CrossRef citations to date
0
Altmetric
Original Articles

Matching adjusted indirect comparisons of efficacy outcomes for idecabtagene vicleucel (ide-cel, bb2121) versus selinexor + dexamethasone and belantamab mafodotin in relapsed and refractory multiple myeloma

Paula Rodriguez-Oteroa Clínica Universidad de Navarra, Pamplona, SpainCorrespondence[email protected]
View further author information
,
Dieter Ayersb PRECISIONheor, Vancouver, BC, CanadaView further author information
,
Shannon Copeb PRECISIONheor, Vancouver, BC, CanadaView further author information
,
Faith E. Daviesc NYU Langone Health, New York, NY, USAView further author information
,
Michel Delforged Department of Hematology, University Hospital Leuven, Leuven, BelgiumView further author information
,
Ali Mojebib PRECISIONheor, Vancouver, BC, CanadaView further author information
,
Jeroen P. Jansenb PRECISIONheor, Vancouver, BC, CanadaView further author information
,
Katja Weisele Department of Oncology, Hematology & Bone Marrow Transplantation, University Medical Center of Hamburg-Eppendorf, Hamburg, GermanyView further author information
,
Kristen Hegef Bristol Myers Squibb, Princeton, NJ, USAView further author information
&
Sujith Dhanasirig Celgene International Sàrl, a Bristol-Myers Squibb Company, Boudry, SwitzerlandView further author information
 show all
Pages 2482-2491 | Received 02 Dec 2020, Accepted 27 Mar 2021, Published online: 24 Apr 2021

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.